After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Fate Therapeutics Inc (FATE) shows that investor sentiment remained same, with the stock’s consolidated last price to $2.51. The Fate Therapeutics Inc has recorded 8,411 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2023 Financial Results.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
Stocks Info
As a NASDAQ listed company, FATE falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $2.51 and fluctuated between $2.5650 as its day high and $2.3400 as its day low. The current market capitalization of Fate Therapeutics Inc is $247.39M. A total of 3.25 million shares were traded on the day, compared to an average of 2.25M shares.
Insider Activity
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, FATE has seen 0 BUY and 1 SELL insider trades, representing the acquisition of 0 and the disposition of 4,718 shares. Over the last 12 months, there were 7 BUYs and 13 SELLs from insiders. Insiders purchased 597,407 shares during that period but sold 107,329.
In the most recent transaction, Dulac Edward J III sold 4,718 shares of FATE for 2.80 per share on Aug 18. After the transaction, the Chief Financial Officer now owns 119,570 company shares. In a previous transaction on Aug 04, Xu Yuan sold 632 shares at 3.71 per share. FATE shares that Director owns now total 9,302.
Among the insiders who sold shares, Dulac Edward J III disposed of 5,182 shares on Jul 05 at a per-share price of $4.83. This resulted in the Chief Financial Officer holding 124,288 shares of FATE after the transaction. In another insider transaction, Powl Brian T. sold 3,854 shares at $4.87 per share on Jul 05. Company shares held by the Chief Commercial Officer now total 41,146.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for FATE in the last 3 months, the mean price target is $7.44 with high estimates of $16.00 and low estimates of $4.00. In terms of 52-week highs and lows, FATE has a high of $23.96 and a low of $1.63.
As of this writing, FATE has an earnings estimate of $Fathom Digital Manufacturing Co per share for the current quarter. EPS was calculated based on a consensus of Fate Therapeutics, Inc. estimates, with a high estimate of $FaZe Holdings Inc. per share and a lower estimate of $FAT Brands Inc.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. FATE’s latest balance sheet shows that the firm has $615.91M in Cash & Short Term Investments as of fiscal 2021. There were $114.82M in debt and $81.28M in liabilities at the time. Its Book Value Per Share was $4.44, while its Total Shareholder’s Equity was $678.84M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for FATE is Buy with a score of 3.52.
